ارزیابی اثر ایمنوگلوبولین داخل وریدی در مبتلایان به سندرم گلین باره، پلی رادیکولونوروپاتی مزمن ایدیوپاتیک و میاستنی گراویس در بیماران بستری بخش نورولوژی بیمارستان امام خمینی از سال 1369 الی 1374

With retrospective evaluation of 44 patients suffering from Guilan-Barre Syndrome (GBS), Chronic Idiopathic Demtyelinative Polyradiculoneuropathy (CIDP) and Myasthenia Gravis (MG) treated with intravenous immunoglobulin, we found following results: 1) Initial symptoms of improvement on forth or fifth days. 2) Maximum recovery for CIDP and MG were after 16-24 and 3-11 days, respectively. 3) No major complication, but mild side effects in 32% of patients. 4) In patients with GBS one grade improvement achieved after 8-30 days. 5) Intravenous immunoglobulin (IVIG) plus plasmapheresis had no advantages over IVIG alone. 6) No reasonable conclusion about relapsing rate and duration of response due to follow up restrictions.